NCT01316601已完成2 期
A Study to Assess Efficacy, Safety and Tolerability of the Anti-IL-13 Monoclonal Antibody QAX576 in the Treatment of Perinanal Fistulas in Patients Suffering From Crohn's Disease
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 3
- 试验地点
- 1
- 主要终点
- complete closure of fistula
研究概览
简要总结
Test safety and efficacy and of a novel IL-13 AB in the treatment of perianal fistulas
- Trial with medicinal product
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •diagnosis of Crohn's disease > 6 month with fistula - at least 1 ineffective fistula treatment in the past
排除标准
- •TNF a antibody treatment failed in the past
- •- planned surgery
结局指标
主要结局
complete closure of fistula
次要结局
未报告次要终点
研究者
Gerhard Rogler
Prof.Dr.Dr. Gerhard Rogler
University of Zurich
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants in MexicoVaccines, PneumococcalNCT00708682Wyeth is now a wholly owned subsidiary of Pfizer225
已完成
3 期
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine Catch-Up Regimens in Older Infants and ChildrenPneumococcal InfectionsNCT00452452Wyeth is now a wholly owned subsidiary of Pfizer355
已完成
1 期
A Study in Healthy Men and Women to Test How Well Different Doses of BI 1323495 Are ToleratedHealthyNCT04107805Boehringer Ingelheim87
已完成
1 期
This Study in Healthy Men Tests How Different Doses of BI 1323495 Are Taken up in the Body and How Well They Are Tolerated.HealthyNCT03588390Boehringer Ingelheim63
已完成
3 期
Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in InfantsVaccines, PneumococcalNCT00366548Wyeth is now a wholly owned subsidiary of Pfizer500